Restless legs syndrome and periodic limb movements

Reviews in Neurological Diseases

Volumn 3, Issue 2, 2006, Pages 61-70

  Vetrugno, Roberto ^a   Provini, Federica ^a   Montagna, Pasquale ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Circadian variations; Dopamine; Dopaminergic agents; Periodic limb movements; Restless legs syndrome; Spinal cord

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CABERGOLINE; CARBAMAZEPINE; CLONAZEPAM; DECARBOXYLASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; IRON; LEVODOPA; MELATONIN; OPIATE; PERGOLIDE; PRAMIPEXOLE; QUININE; ROPINIROLE; ROTIGOTINE; SEROTONIN UPTAKE INHIBITOR;

CIRCADIAN RHYTHM; DIENCEPHALON; DIFFERENTIAL DIAGNOSIS; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG EFFICACY; FAMILY HISTORY; HUMAN; LEG CRAMP; MOTOR DYSFUNCTION; MYOCLONUS; NEUROPHYSIOLOGY; NIGRONEOSTRIATAL SYSTEM; PATHOGENESIS; PERIODIC LIMB MOVEMENT DISORDER; RESTLESS LEGS SYNDROME; REVIEW; SENSORIMOTOR FUNCTION;

CIRCADIAN RHYTHM; DOPAMINE; HISTORY, 17TH CENTURY; HISTORY, 19TH CENTURY; HUMANS; NOCTURNAL MYOCLONUS SYNDROME; RESTLESS LEGS SYNDROME;

EID: 33745609776     PISSN: 15452913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (131)

1. Ekbom KA. Restless legs: a clinical study. Acta Med Scand. 1945;158(suppl):1-122.
2. Lugatesi E, Coccagna G, Berti Ceroni G, Ambrosetto C. Restless legs syndrome and nocturnal myoclonus. In: Gastout H, Lugaresi E, Berti-Ceroni G, Coccagna G, eds. The Abnormalities of Sleep in Man. Bologna, Italy. Aulo Gaggi Editore; 1968:285-294.
3. Akpinar S. Restless legs syndrome treatment with dopaminergic drags. Clin Neuropharmacol. 1987;10:69-79.
4. Walters AS. Toward a better definition of the restless legs syndrome. The international Restless Legs Syndrome Study Group. Mov Disord. 1995;10:634-642.
5. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health. Sleep Med. 2003;4:101-119.
6. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160:2137-2141.
7. Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med. 2004;5:293-299.
8. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors for RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology. 2000;54:1064-1068.
9. Berger K, Luedemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164:196-202.
10. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact. REST general population study. Arch Intern Med. 2005;165:1286-1292.
11. Picchietti DL, Underwood DJ, Farris WA, et al. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord. 1999;14:1000-1007.
12. Chervin RD, Archbold KH, Dillon JE, et al. Association between symptoms of inattention, hyperactivity, restless legs, and periodic limb movements. Sleep. 2002;25:213-218.
13. Rajaram SS, Walters AS, England SJ, et al. Some children with growing pains may actually have restless legs syndrome. Sleep. 2004;27:767-773.
14. Ekbom KA. Restless legs syndrome. Neurology. 1960;10:868-873.
15. Manconi M, Govoni V, De Vito A, et al. Restless legs syndrome and pregnancy. Neurology. 2004; 63:1065-1069.
16. Montagna P, Coccagna P, Cirignotta F, et al. Familial restless legs syndrome: long-term follow-up. In: Guilleminault C, Lugaresi E, eds. Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution. New York, NY: Raven Press; 1983:231-235.
17. Ondo WG, Vuong KD, Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology. 2000;55:1404-1406.
18. Desai AV, Cherkas LF, Spector TD, et al. Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin study. Twin Res. 2004;7:589-595.
19. Winkelmann J, Muller-Myhsok B, Wittchen HU, et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of Inheritance in early age at onset families. Ann Neurol. 2002; 52:297-302.
20. Winkelmann J, Wetter TC, Collado-Seidel V, et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 2000;23:597-602.
21. Desautels A, Turecki G, Montplaisir J, et al. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet. 2001;69:1266-1270.
22. Desautels A, Turecki G, Montplaisir J, et al. Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol. 2005; 62:591-596.
23. Bonati MT, Ferini-Strambi L, Aridon P, et al. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain. 2003;126:1485-1492.
24. Levchenko A, Montplaisir JY, Dube MP, et al. The 14q restless legs syndrome locus in the French Canadian population. Ann Neurol. 2004;55:887-891.
25. Chen S, Ondo WG, Rao S, et al. Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet. 2004;74:876-885.
26. Morgan LK. Restless limbs: a commonly overlooked symptom controlled by valium. Med J Aust. 1967;2:589-594.
27. Walters AS. Frequent occurrence of myoclonus while awake and at rest, body rocking and marching in place in a subpopulation of patients with restless legs syndrome. Acta Neurol Scand. 1988;77:418-421.
28. Lombardi C, Provini F, Vetrugno R, et al. Pelvic movements as rhythmic manifestation associated with restless legs syndrome. Mov Disord. 2003;18:110-113.
29. Chervin RD, Consens FB, Kutluay E. Alternating leg muscles activation during sleep and arousals: a new sleep-related motor phenomenon? Mov Disord. 2003;18:551-559.
30. Vetrugno R, Provini F, Plazzi G, et al. Propriospinal myoclonus: a motor phenomenon found in restless legs syndrome different from periodic limb movements during sleep. Mov Disord. 2005;20:1323-1329.
31. Symonds CP. Nocturnal myoclonus. Neurol Neurosurg Psychiatry. 1953;16:166-171.
32. Lugaresi E, Cirignotta F, Coccagna G, Montagna P. Nocturnal myoclonus and restless legs syndrome. Adv Neurol. 1986;43:295-307.
33. Coleman RM, Pollak CP, Weitzman ED. Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders. Ann Neurol. 1980;8:416-421.
34. Montplalsir J, Boucher S, Poirier G, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12:61-65.
35. Chabli A, Michaud M, Montplaisir J. Periodic arm movements in patients with the restless legs syndrome. Eur Neurol. 2000;44:133-138.
36. Provini F, Vetrugno R, Meletti S, et al. Motor pattern of periodic limb movements during sleep. Neurology. 2001;57:300-304.
37. de Weerd AW, Rijsman RM, Brinkley A. Activity patterns of leg muscles in periodic limb movement disorder. J Neurol Neurosurg Psychiatry. 2004;75:317-319.
38. Coleman RM. Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C, ed. Sleeping and Waking Disorders: Indications and Technique. Menlo Park, CA: Addison-Wesley; 1982:265-295.
39. Recording and scoring leg movements. The atlas task force. Sleep. 1993;16:748-759.
40. Zucconi M, Ferri R, Allen R, et al. The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med. 2006;7:175-183.
41. American Academy of Sleep Medicine. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd ed. Westchester, IL: 2005.
42. Lugaresi E, Coccagna G, Mantovani M, Lebrun R. Some periodic phenomena arising during drowsiness and sleep in man. Electroencephalogr Clin Neurophysiol. 1972;32:701-705.
43. Sforza E, Jouny C, Ibanez V. Time course of arousal response during periodic leg movements in patients with periodic leg movements and restless legs syndrome. Clin Neurophysiol. 2003;114:1116-1124.
44. Haba-Rubio J, Staner L, Cornette F, et al. Acute low single dose of apomorphine reduces periodic limb movements but has no significant effect on sleep arousal: a preliminary report. Clin Neurophysiol. 2003;33:180-184.
45. Pollmacher T, Schulz H. Periodic leg movements (PLM): their relationship to sleep stages. Sleep. 1993;16:572-577.
46. Parrino L, Boselli M, Buccino GP, et al. The cyclic alternating pattern plays a gate-control on periodic limb movements during non-rapid eye movement sleep. J Clin Neurophysiol. 1996; 13:314-323.
47. Terzano MG, Parrino L, Sherieri A, et al. Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleep. Sleep Med. 2001;2:537-555.
48. Montplaisir J, Boucher S, Nicolas A, et al. Immobilization tests and periodic limb movements in sleep for the diagnosis of restless leg syndrome. Mov Disord. 1998;13:324-329.
49. Montplaisir J, Godbout R. Nocturnal sleep of narcoleptic patients: revisited. Sleep. 1986;9:159-161.
50. Fry JM, DiPhillipo MA, Pressman MR. Periodic leg movements in sleep following treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Chest. 1989;96:89-91.
51. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behaviour disorder: development of a scoring method. Neurology. 1992;42:1371-1374.
52. Vetrugno R, Liguori R, Provini F, et al. Continuous motor unit activity syndromes: a videopolysomnographic study. Clin Neurophysiol. 2005;116:2533-2541.
53. Vetrugno R, Provini F, Cortelli P, et al. Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study. Sleep Med. 2004;5:21-30.
54. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Periodic limb movements in sleep in community-dwelling elderly. Sleep. 1991;14:496-500.
55. Roehrs T, Zorick F, Sicklesteed J, et al. Age-related sleep-wake disorders at a sleep disorder center. J Am Geriatr Soc. 1983;31:364-370.
56. Mendelson WB. Are periodic leg movements associated with clinical sleep disturbance? Sleep. 1996;19:219-223.
57. Nicolas A, Lesperance P, Montplaisir J. Is excessive daytime sleepiness with periodic leg movements during sleep a specific diagnostic category? Eur Neurol. 1998;40:22-26.
58. Haba-Rubio J, Staner L, Krieger J, Macher JP. What is the clinical significance of periodic limb movements during sleep? Neurophysiol Clin. 2004;34:293-300.
59. Trenkwalder C, Hening WA, Walters AS, et al. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord. 1999;14:102-110.
60. Hening WA, Walters AS, Wagner M, et al. Circadian rhythm of motor restlessness and sensory symptoms in idiopathic restless legs syndrome. Sleep. 1999;22:901-912.
61. Michaud M, Dumont M, Selmaoui B, et al. Circadian rhythm of restless legs syndrome: relationship with biological markers. Ann Neurol. 2004;55:372-380.
62. Boecker MR, Badia P, Shaffer JI. The relationship between core temperature and time-of-the night patterns in PLMS activity. Sleep Res. 1995;23:235.
63. Tribl GG, Waldhauser F, Sycha T, et al. Urinary 6-hydroxy-melatonin- sulfate excretion and circadian rhythm in patients with restless legs syndrome. J Pineal Res. 2003;35:295-296.
64. Wetter TC, Collado-Seidel V, Oertel H, et al. Endocrine rhythms in patients with restless legs syndrome. J Neurol 2002;294:146-151.
65. Sowers JR, Vlachakis N. Circadian variation in plasma dopamine levels in man. J Endocrinol Invest. 1984;7:341-345.
66. Perlow MJ, Gordon EK, Ebert ME, et al. The circadian variation in dopamine metabolism in subhuman primate. J Neurochem. 1977;28:1381-1383.
67. Castaneda TR, de Prado BM, Prieto O, Mora F. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res. 2004;36:177-185.
68. Schade R, Vick K, Ott T, et al. Circadian rhythms of dopamine and cholecystokinin in nucleus accumbens and striatum of rats-influence on dopamine stimulation. Chronobiol Int. 1995;12:87-99.
69. Kawano Y, Kawasaki T, Kawazoe N, et al. Circadian variations of urinary dopamine, norepinephrine, epinephrine and sodium in normotensive and hypertensive subjects. Nephron. 1990;55:277-282.
70. Wilkes MM, Babaknia A, Hoff JD, et al. Circadian rhythm in circulating concentration of dihydroxyphenylacetic acid in normal women. J Clin Endocrinol Metab. 1981;52:608-611.
71. Abrahamson EE, Moore RY. Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections. Brain Res. 2001;916:172-191.
72. Skagerberg G, Lindvall O. Organization of diencephalic dopamine neurons projecting to the spinal cord in the rat. Brain Res. 1985;342:340-351.
73. Holstege JC, van Fijken H, Bujis RM, et al. Distribution of dopamine immunoreactivity in the rat, cat, and monkey spinal cord. J Comp Neurol. 1996;376:631-652.
74. Fleetwood-Walker SM, Coote JH. Contribution of noradrenaline-dopamine- and adrenaline-containing axons to the innervation of different regions of the spinal cord of the cat. Brain Res. 1981;206:95-106.
75. Commissiong JW, Sedgwick EM. Dopamine and noradrenaline in human spinal cord (Letter). Lancet. 1975;1:347.
76. Eisensehr I, Watter TC, Linke R, et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology. 2001;57:1307-1309.
77. Tribl GG, Asenbaum S, Klosch G, et al. Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome. Neurology. 2002;59:649-650.
78. Staedt J, Stoppe G, Kogler A, et al. Single photon emission tomography (SPECT) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). J Neural Transm Gen Sect. 1995;99:187-193.
79. Michaud M, Sonuy JP, Chabli A, et al. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol. 2002;249:164-170.
80. Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord. 2000;15(1):154-158.
81. Wetter TC, Eisensehr I, Trenkwalder C. Functional neuroimaging studies in restless legs syndrome. Sleep Med. 2004;5:401-406.
82. Qu S, Ondo WG, Zhang X, et al. Projections of diencephalic dopamine neurons into the spinal cord in mice. Exp Brain Res. 2006;168:152-156.
83. Etgen T, Draganski B, Ilg C, et al. Bilateral thalamic gray matter changes in patients with restless legs syndrome. Neuroimage. 2005;24:1242-1247.
84. Earley CJ, Hyland K, Allen R. Circadian changes in CSF dopaminergic measures in restless legs syndrome. Sleep Med. 2006;7:263-268.
85. Garcia-Borregueio D, Larrosa O, Granizo JJ, et al. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome. Sleep. 2004;15:669-673.
86. Clemens S, Hochman S. Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice. J Neurosci. 2004;24:11337-11345.
87. Carlsson A, Svennerholm L, Winblad B. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand Suppl. 1980;280:75-85.
88. Clemens S, Sawchuk MA, Hochman S. Reversal of the circadian expression of tyrosine-hydroxylase but not nitric oxide synthase levels in the spinal cord of dopamine D3 receptor knockout mice. Neuroscience. 2005;133:353-357.
89. Hogl B, Kiechl S, Willeit J, et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology. 2005; 64:1920-1924.
90. Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentration of ferritin and transferrin in restless legs syndrome. Neurology. 2000;25:1698-1700.
91. Mizuno S, Mihara T, Miyaoka T, et al. CSF iron, ferritin, and transferrin levels in restless legs syndrome. J Sleep Res. 2005;14:43-47.
92. Allen RP, Barker PB, Wehrl F, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56:263-265.
93. Koeppen AH. The history of iron in the brain. J Neurol Sci. 1995;134(suppl):1-9.
94. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61:304-306.
95. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology. 2004;62:1563-1567.
96. Haba-Rubio J, Staner L, Petiau C, et al. Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry. 2005;76:1009-1010.
97. Wang X, Wiesinger J, Beard J, et al. Thy1 expression in the brain is affected by iron and is decreased in restless legs syndrome. J Neurol Sci. 2004;220:59-66.
98. Salvi F, Montagna P, Plasmati R, et al. Restless legs syndrome and nocturnal myoclonus: initial clinical manifestation of familial amyloid polyneuropathy. J Neurol Neurosurg Psychiatry. 1990;53:522-525.
99. Iannaccone S, Zucconi M, Marchettini P, et al. Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord. 1995;10:2-9.
100. Polydefkis M, Allen RP, Hauer P, et al. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology. 2000;55:1115-1121.
101. Happe S, Zeitlhofer J. Abnormal cutaneous thermal thresholds in patients with restless legs syndrome. J Neurol. 2003;250:362-365.
102. De Mello MT, Lauro FA, Silva DL, Tufik S. Incidence of periodic leg movements and of the restless legs syndrome during sleep following acute physical activity in spinal cord injury subjects. Spinal Cord. 1996;34:294-296.
103. De Mello MT, Poyares DL, Tufik S. Treatment of periodic leg movements with a dopamineigic agonist in subjects with total spinal cord lesions. Spinal Cord. 1999;37:634-637.
104. Hogl B, Frauscher B, Seppi K, et al. Transient restless legs syndrome after spinal anesthesia: a prospective study. Neurology. 2002;59:1705-1707.
105. Poewe W, Hogl B. Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease. Neurology. 2004;26(suppl 3):12-16.
106. Iranzo A, Santamaria J, Tolosa E. Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Lancet. 2000; 356:1329-1330.
107. Abele M, Burk K, Laccone F, et al. Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3. J Neurol. 2001;248:311-314.
108. Trenkwalder C, Bucher SF, Oertel WH et al. Bereitschaftspotential in idiopathic and symptomatic restless legs syndrome. Electroencephalogr Clin Neurophysiol. 1993;89:95-103.
109. Tergau F, Wischer S, Paulus W. Motor system excitability in patients with restless legs syndrome. Neurology. 1999;52:1060-1063.
110. Bucher SF, Seelos KC, Oertel WH, et al. Cerebral generators involved in the pathogenesis of restless legs syndrome. Ann Neurol. 1997;41:639-645.
111. Trenkwalder C, Bucher SF, Oertel WH. Electrophysiological pattern of involuntary limb movements in restless legs syndrome. Muscle Nerve. 1996;19:155-162.
112. Yokota T, Hirose K, Tanabe H, Tsukagoshi H. Sleep-related periodic leg movements (nocturnal myoclonus) due to spinal cord lesion. J Neurol Sci. 1991;104:13-18.
113. Lee Ms, Choi YC, Lee SH, Lee SB. Sleep related periodic leg movements associated with spinal cord lesions. Mov Disord. 1996;11:719-722.
114. Bara-Jimenez W, Aksu M, Graham B, et al. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology. 2000;54:1609-1616.
115. Rijsman RM, Stam CJ, Weerd AW. Abnormal H-reflexes in periodic limb movement disorder: impact on understanding the pathophysiology of the disorder. Clin Neurophysiol. 2005;116:204-210.
116. Navarrete R, Slawinska U, Vrbova G. Electromyographic activity patterns of ankle flexor and extensor muscles during spontaneous and L-DOPA-induced locomotion in freely moving neonatal rats. Adv Neurol. 2001;87:11-24.
117. Jankowska E, Jukes MG, Lund S, Lundberg A. The effect of DOPA on the spinal cord. 5. Reciprocal organization of pathways transmission excitatory action to alpha motoneurones of flexors and extensors. Acta Physiol Scand. 1967; 70:369-388.
118. Rossignol S, Dubuc R, Gossard JP. Dynamic sensorimotor interaction in locomotion. Physiol Rev. 2006;86:89-154.
119. Schattschneider J, Bode A, Wasner G, et al. Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. J Neurol. 2004;251:977-982.
120. Stiasny-Kolster K, Magerl W, Oertel WH, et al. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain. 2004;127:773-782.
121. Montagna P, Sassoli de Bianchi L, Zucconi M, et al. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand. 1984;69:428-430.
122. Comella CL. Restless legs syndrome. Treatment with dopaminergic agents. Neurology. 2002; 58(suppl):87-92.
123. Allen RP, Earley CJ. Augmentation of restless legs syndrome with carbidopa/levodopa. Sleep. 1996;19:205-213.
124. Vetrugno R, Contin M, Baruzzi A, et al. Polysomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome. Mov Disord. 2006;21:254-258.
125. Vignatelli L, Billiard M, Clarenbach P, et al. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. Eur J Neurol. In press.
126. Chesson AL, Wise M, Davila D, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 1999;22:961-968.
127. Stiasny-Kolster K, Kohnen R, Schollmayer E, et al. 666 Study Group. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Mov Disord. 2004;19:1432-1438.
128. Horvath J, Fross RD, Kleiner-Fisman G, et al. Severe multivalvular heart disease: a new complication of ergot derivative dopamine agonist. Mov Disord. 2004;19:656-662.
129. Danoff SK, Grasso ME, Terry PB, Flynn JA. Pleuropulmonary disease due to pergolide use for restless legs syndrome. Chest. 2001;120:313-316.
130. Garcia-Boneguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology. 2002;59:1573-1579.
131. Hening WA, Walters A, Kavey N, et al. Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids. Neurology. 1986;36:1363-1366.